Showing results (11-20 of 1,217) with videos related to
Sort By:
Pageof 122
Journal of Psychiatry & Neuroscience : JPN|December 9, 2010
Effect of executive functioning, decision-making and self-reported impulsivity on the treatment outcome of pathologic gamblingEva M Alvarez-Moya, Cristian Ochoa, Susana Jiménez-Murcia, et al.Journal of Psychiatry & Neuroscience : JPN|August 25, 2010
Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicideAlexander McGirr, Gabriel Diaconu, Marcelo T Berlim, et al.Journal of Psychiatry & Neuroscience : JPN|March 1, 1991
Clinical trials in dementia: learning effects with repeated testingJ J Claus, E Mohr, T N ChaseJournal of Psychiatry & Neuroscience : JPN|June 24, 2010
Osteoprotegerin levels in patients with severe mental disordersSigrun Hope, Ingrid Melle, Pål Aukrust, et al.Journal of Psychiatry & Neuroscience : JPN|June 24, 2010
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illnessYi Che, Jun-Feng Wang, Li Shao, et al.Journal of Psychiatry & Neuroscience : JPN|June 24, 2010
Orbitofrontal volume reductions during emotion recognition in patients with major depressionJohanna Scheuerecker, Eva M Meisenzahl, Nikolaos Koutsouleris, et al.Journal of Psychiatry & Neuroscience : JPN|June 24, 2010
Brain volumes in psychotic youth with schizophrenia and mood disordersMohamed El-Sayed, R Grant Steen, Michele D Poe, et al.Journal of Psychiatry & Neuroscience : JPN|April 6, 2011
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET studyJulia Sacher, Sylvain Houle, Jun Parkes, et al.Journal of Psychiatry & Neuroscience : JPN|July 1, 1997
Quality of life and social integration of severely mentally ill patients: a longitudinal studyR Tempier, C Mercier, P Leouffre, et al.Journal of Psychiatry & Neuroscience : JPN|July 1, 1997
Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophreniaD A RevickiPageof 122